Summary
Five healthy subjects were each given fluoride 3.0 mg (F) as sodium fluoride tablets on two occasions — during production of acid urine, induced by giving NH4Cl, and during production of alkaline urine obtained by giving NaHCO3. Frequent plasma and urine samples were taken up to 12 h and were analyzed with a F− sensitive electrode. Control experiments without F administrations were also performed to permit calculation of net F concentration in plasma and urine. The urine F excretion was lower during acid than alkaline diuresis. Pharmacokinetic analysis of the net plasma F concentrations showed that the apparent plasma half-life of F was longer when urine was acid (4.3±0.6 h: SD; n=5) than when it was alkaline (2.4±0.4 h). This could be explained by changes in the renal clearance of F, which was always lower with an acid (61.5±8.1 ml/min) than an alkaline (97.8±10.4 ml/min) urine. The apparent extra-renal clearance, which mainly represents clearance to the bone-pool, was also significantly higher during production of alkaline (109.2±20.2 ml/min) than of acid (86.3±21.3 ml/min) urine. It is suggested, that increased reabsorption of non-ionic hydrogen fluoride (HF) is responsible for the decreased renal clearance during acidic conditions.
Similar content being viewed by others
References
Adler P (1970) Fluorides and dental health. In: Fluorides and human health. W. H. O. Monograph Series No. 59. Geneva, pp 323–354
Barzel US, Jowsey J (1969) The effects of chronic acid and alkali administration on bone turnover in adult rats. Clin Sci 36: 517–524
Becket AH, Rowland M (1965) Urinary excretion on kinetics of amphetamins in man. J Pharm Pharmacol 17: 628–639
Carlsson CH, Armstrong WD, Singer L (1960) Distribution and excretion of radiofluoride in the human. Proc Soc Exp Biol Med 104: 235–239
Chen PS Jr, Smith FA, Gardner DE, O'Brien JA, Hodge HC (1956) Renal clearance of fluoride. Proc Soc Exp Biol Med 92: 879–883
Cousins MJ, Mazze RI (1973) Methoxyflurane nephrotoxicity: A study of dose response in man. J Am Med Assoc 255: 1611–1616
Cousins MJ, Mazze RI, Kosek JC, Hitt BA, Love FV (1974) The etiology of methoxyflurane nephrotoxicity. J Pharmacol Exp Ther 190: 530–541
Cousins MJ, Greenstein LR, Hitt BA, Mazze RI (1976) Metabolism and renal effect of enflurane in man. Anesthesiology 44: 44–53
Ekstrand J (1977) A micromethod for determination of fluoride in blood plasma and saliva. Calcif Tissue Res 23: 225–228
Ekstrand J, Alván G, Boréus LO, Norlin A (1977) Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol 12: 311–317
Ekstrand J, Ehrnebo M, Boréus LO (1978) Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin Pharmacol Ther 23: 329–337
Eriksson E, Granberg PO, Örtergran B (1966) Study of renal excretion of prilocaine and lidocaine. Acta Chir Scand Suppl 358: 55–69
Franke J, Rempel H, Franke M (1974) Three years experience with sodium-fluoride therapy of osteoporosis. Acta Orthop Scand 45: 1–20
Goldstein AL, Aronoq L, Kalman SM (1968) In: Principles of drug action. Harper & Row, New York, pp 381–384
Harmon C, Whitford GM, Pashley DH, Reynolds KE, Stock H (1976) pH-dependence of fluoride renal clearance in dogs. Soc Exp Biol Med (Southeastern Section), Abstract 13
Henschler D, Büttner W, Patz J (1975) Absorption distribution in body fluids and bioavailability of fluoride. In: Kuhlencordt F, Kruse HP (eds) Calcium metabolism, bone and metabolic bone diseases. Springer, Berlin Heidelberg New York, pp 111–121
Hodge HC, Smith FA (1965) Biological properties of inorganic fluorides. In: Simons JH (ed) Fluorine chemistry, vol IV. Academic Press, New York
Horowitz HS (1977) Missuse of topically applied fluorides. J Am Soc Prevent Dent 7 (2): 15–16
Jowsey J, Riggs BL, Kelly PJ (1975) Long-term experience with fluoride and fluoride combination treatment of osteoporosis In: Kuhlencordt F, Kruse HP (eds) Calcium metabolism, bone and metabolic bone diseases. Springer, Berlin Heidelberg New York, pp 151–154
Patel PR, Moreno EC, Patel JM (1971) Ionization of hydrofluoric acid at 25°C. J Res Nat Bur Stand Sect A 75: 205–211
Pitts RF Jr (1974) Physiology of the kidney and body fluids. Year Book Publishers, Chicago, pp 217–221
Reynolds KE, Whitford GM, Pashley DH (1978) Acute fluoride toxicity: the influence of acid-base status. Toxicol Appl Pharmacol 45: 415–427
Whitford GM, Pashley DH (1979) The effect of body fluid pH on fluoride distribution. Toxicity and renal clearance. In: Johansen E, Taves DR, Olsen TO (eds) Continuing evaluation of the use of fluorides. A. A. A. S. Selected Symposium No. 11, Chapt. 8. Westview Press, Boulder, Colorado, pp 187–221
Whitford GM, Taves DR (1973) Fluoride induced diuresis: renal tissue solute concentrations, functional, hemodynamic, and histologic correlates in the rat. Anesthesiology 39: 416–427
Whitford GM, Pashley DH, Stringer GI (1976) Fluoride renal clearance: a pH-dependent event. Am J Physiol 230: 527–532
Whitford GM, Pashley DH, Reynolds KE (1977) Fluoride absorption from the rat urinary bladder: a pH-dependent event. Am J Physiol 232 (1): F10-F15
Whitford GM, Reynolds KE, Pashley DH (1979a) Acute fluoride toxicity: the influence of metabolic alkalosis. Toxicol Appl Pharmacol: 50: 31–39
Whitford GM, Pashley DH, Reynolds KE (1979b) Stop flow studies on the renal handling of fluoride. J Dent Res 58 (Special Issue A, Abstract 1257, p 405)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ekstrand, J., Ehrnebo, M., Whitford, G.M. et al. Fluoride pharmacokinetics during acid-base balance changes in man. Eur J Clin Pharmacol 18, 189–194 (1980). https://doi.org/10.1007/BF00561589
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561589